Payment overview · 2025
General Payments
$49.21
2 reported records · 1 companies
Healthcare provider profile · identity verified
Carla Fleming, NP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · CLINTWOOD, VA · NPI 1588811103
Verified facts
What the public records show
CMS Open Payments records show Carla Fleming, NP received $49.21 in general payments during 2025 across 2 reported records.
ABBVIE INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Vraylar.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Vraylar by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $49.21 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $49.21 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $49.21 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| VRAYLAR vraylar |
2025 | Vraylar | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
42 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 796 | 106 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 730 | 97 |
| Levothyroxine Sodium | Levothyroxine Sodium | 680 | 105 |
| Omeprazole | Omeprazole | 524 | 89 |
| Lisinopril | Lisinopril | 508 | 85 |
| Amlodipine Besylate | Amlodipine Besylate | 499 | 79 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 496 | 84 |
| Montelukast Sodium | Montelukast Sodium | 441 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 438 | 69 |
| Losartan Potassium | Losartan Potassium | 425 | 71 |
| Pravastatin Sodium | Pravastatin Sodium | 406 | 64 |
| Atorvastatin Calcium | Atorvastatin Calcium | 396 | 65 |
| Metformin Hcl | Metformin Hcl | 371 | 64 |
| Glipizide Er | Glipizide | 321 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 320 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 311 | 50 |
| Sertraline Hcl | Sertraline Hcl | 302 | 45 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 297 | 40 |
| Atenolol | Atenolol | 290 | 44 |
| Furosemide | Furosemide | 282 | 55 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 276 | 57 |
| Alprazolam | Alprazolam | 261 | 30 |
| Meloxicam | Meloxicam | 242 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 238 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 238 | 36 |
| Fluoxetine Hcl | Fluoxetine Hcl | 225 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 225 | 38 |
| Zolpidem Tartrate | Zolpidem Tartrate | 222 | 26 |
| Potassium Chloride | Potassium Chloride | 214 | 41 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 207 | 27 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 207 | 33 |
| Ibuprofen | Ibuprofen | 200 | 42 |
| Oxycodone Hcl | Oxycodone Hcl | 191 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 177 | 23 |
| Simvastatin | Simvastatin | 170 | 32 |
| Eliquis | Apixaban | 159 | 26 |
| Tramadol Hcl | Tramadol Hcl | 154 | 23 |
| Ibandronate Sodium | Ibandronate Sodium | 151 | 32 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 151 | 22 |
| Trazodone Hcl | Trazodone Hcl | 148 | 23 |
| Lansoprazole | Lansoprazole | 147 | 21 |
| Januvia | Sitagliptin Phosphate | 145 | 22 |
| Famotidine | Famotidine | 135 | 27 |
| Carvedilol | Carvedilol | 131 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 125 | 16 |
| Clonazepam | Clonazepam | 122 | 15 |
| Lorazepam | Lorazepam | 120 | 16 |
| Aripiprazole | Aripiprazole | 112 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 108 | 19 |
| Bupropion Xl | Bupropion Hcl | 107 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 107 | 19 |
| Celecoxib | Celecoxib | 106 | 19 |
| Allopurinol | Allopurinol | 104 | 15 |
| Ozempic | Semaglutide | 104 | 20 |
| Finasteride | Finasteride | 103 | 15 |
| Glipizide | Glipizide | 101 | 14 |
| Mirtazapine | Mirtazapine | 101 | 17 |
| Trulicity | Dulaglutide | 96 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 93 | 19 |
| Azithromycin | Azithromycin | 90 | 78 |
| Jardiance | Empagliflozin | 87 | 14 |
| Prednisone | Prednisone | 86 | 53 |
| Diazepam | Diazepam | 83 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 18 |
| Baclofen | Baclofen | 78 | 14 |
| Buspirone Hcl | Buspirone Hcl | 77 | 12 |
| Propranolol Hcl | Propranolol Hcl | 75 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 71 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 70 | 13 |
| Pregabalin | Pregabalin | 70 | 11 |
| Warfarin Sodium | Warfarin Sodium | 68 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 67 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 63 | 12 |
| Meclizine Hcl | Meclizine Hcl | 62 | 13 |
| Ezetimibe | Ezetimibe | 61 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 60 | suppressed |
| Verapamil Er | Verapamil Hcl | 59 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 58 | suppressed |
| Febuxostat | Febuxostat | 53 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 14 |
| Metformin Hcl Er | Metformin Hcl | 51 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 51 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 51 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 46 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 45 | suppressed |
| Spironolactone | Spironolactone | 45 | suppressed |
| Levofloxacin | Levofloxacin | 43 | 30 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 42 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 42 | suppressed |
| Methocarbamol | Methocarbamol | 42 | suppressed |
| Mounjaro | Tirzepatide | 42 | suppressed |
| Synthroid | Levothyroxine Sodium | 42 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 41 | 34 |
| Fluconazole | Fluconazole | 41 | 21 |
| Ranolazine Er | Ranolazine | 41 | suppressed |
| Sucralfate | Sucralfate | 41 | 11 |
| Topiramate | Topiramate | 41 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 16 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Amoxicillin | Amoxicillin | 38 | 27 |
| Carisoprodol | Carisoprodol | 38 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 37 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 35 | 11 |
| Cephalexin | Cephalexin | 33 | 18 |
| Methotrexate | Methotrexate Sodium | 33 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 33 | suppressed |
| Temazepam | Temazepam | 32 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Valsartan | Valsartan | 31 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | suppressed |
| Lactulose | Lactulose | 30 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 29 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 28 | suppressed |
| Naproxen | Naproxen | 28 | suppressed |
| Desloratadine | Desloratadine | 27 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Dutasteride | Dutasteride | 26 | suppressed |
| Glimepiride | Glimepiride | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Irbesartan | Irbesartan | 24 | suppressed |
| Pen Needles | Pen Needle, Diabetic | 24 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 24 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 23 | suppressed |
| Gemfibrozil | Gemfibrozil | 23 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 23 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Vraylar | Cariprazine Hcl | 23 | suppressed |
| Nystatin | Nystatin | 22 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 21 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 21 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 18 |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Lidocaine | Lidocaine | 20 | suppressed |
| Memantine Hcl | Memantine Hcl | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 19 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 19 | suppressed |
| Colchicine | Colchicine | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Cefdinir | Cefdinir | 17 | 17 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Ibu | Ibuprofen | 17 | suppressed |
| Torsemide | Torsemide | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Ursodiol | Ursodiol | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 13 | suppressed |
| Cimetidine | Cimetidine | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Lexapro | Escitalopram Oxalate | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Ramelteon | Ramelteon | 13 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Meprobamate | Meprobamate | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Nexium | Esomeprazole Magnesium | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 11 | suppressed |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Effexor Xr | Venlafaxine Hcl | 11 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $49.21 · 2 records | ABBVIE INC. | VRAYLAR | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Vraylar play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error